Alpha Tau Medical News

Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect In Pancreatic Murine Tumor Models At ESTRO 2024 Congress In Glasgow; Initial Data Demonstrates Reduction In Distant Pancreatic Cancer Tumor Growth Rate Starting From 3-Weeks...

Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect In Pancreatic Murine Tumor Models At ESTRO 2024 Congress In Glasgow; Initial Data Demonstrates Reduction In Distant Pancreatic

BenzingaMay 6 20:37

Alpha Tau to Participate in May Investor Conferences

JERUSALEM, May 01, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, t

GlobeNewswireMay 1 20:30

Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit

JERUSALEM, March 25, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT,

GlobeNewswireMar 25 20:50

Buy Rating Affirmed: Anticipating Alpha Tau Medical's Clinical Milestones and Growth Potential in 2024

TipRanksMar 13 00:25

HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

BenzingaMar 13 00:19

Alpha Tau Medical Price Target Cut to $7.00/Share From $8.00 by Piper Sandler

Alpha Tau Medical Price Target Cut to $7.00/Share From $8.00 by Piper Sandler

Dow JonesMar 8 23:01

Piper Sandler Reiterates Overweight on Alpha Tau Medical, Lowers Price Target to $7

Piper Sandler analyst Jason Bednar reiterates Alpha Tau Medical with a Overweight and lowers the price target from $8 to $7.

Analyst UpgradesMar 8 22:51

Alpha Tau Medical Ltd (DRTS) Gets a Buy From Piper Sandler

TipRanksMar 8 20:47

Alpha Tau Medical GAAP EPS of -$0.42

Seeking AlphaMar 8 06:37

Press Release: Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update

Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update - Positive interim safety and feasibility data from pancreatic cancer study in Montreal, with initial signs

Dow JonesMar 8 05:01

Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference

JERUSALEM, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT,

GlobeNewswireFeb 26 21:30

Alpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth Plans

Yahoo FinanceFeb 23 21:46

Is Alpha Tau Medical (DRTS) Stock Outpacing Its Medical Peers This Year?

Yahoo FinanceJan 22 22:40

Alpha Tau Medical Ltd. (NASDAQ:DRTS) Most Popular Amongst Retail Investors Who Own 58%, Insiders Hold 22%

Yahoo FinanceJan 13 21:47

12 Health Care Stocks Moving In Wednesday's After-Market Session

GainersReshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 6.7% to $0.26 during Wednesday's after-market session. The company's market cap stands at $4.8 million. Semler Scientific (NASDAQ:SMLR)

BenzingaJan 11 05:31

Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference

- The overview presentation will review some of the Company's recent achievements, including highly promising interim results from the Company's pancreatic cancer safety and feasibility trial as well

GlobeNewswireDec 20, 2023 22:15

Expert Ratings for Alpha Tau Medical

Alpha Tau Medical (NASDAQ:DRTS) has observed the following analyst ratings within the last quarter: BullishSomewhat BullishIndifferentSomewhat BearishBearishTotal Ratings31000Last 30D100001M Ago110002

BenzingaDec 15, 2023 23:01

Citigroup Initiates Coverage On Alpha Tau Medical With Buy Rating, Announces Price Target of $8

Citigroup analyst Ashiq Mubarack initiates coverage on Alpha Tau Medical (NASDAQ:DRTS) with a Buy rating and announces Price Target of $8.

BenzingaDec 15, 2023 22:43

Sidoti Events, LLC's Virtual December Small-Cap Conference

NEW YORK, NY / ACCESSWIRE / December 5, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day December Small-Cap Confere

AccesswireDec 5, 2023 23:25

Press Release: Alpha Tau to Participate in Sidoti Small-Cap Conference

Alpha Tau to Participate in Sidoti Small-Cap Conference JERUSALEM, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the developer of the

Dow JonesNov 29, 2023 21:30